📄 What This Document Is

This is a 6-K filing, which is a report a foreign company (in this case, Tokyo-based Perpetuals) submits to the SEC to announce major news to U.S. investors. It's essentially a press release about a new business initiative.

👉 Why it matters: This isn't a routine financial update. It's a major strategic announcement about entering a completely new industry—healthcare—which could significantly change the company's future.

🏢 What The Company Does

In simple terms, Perpetuals.com Ltd (PDC) is a fintech company that uses artificial intelligence for trading and prediction markets. Think of it as a tech firm building AI tools to help people make better financial decisions in a complex, fast-moving market.

The company operates globally and owns its own licensed trading infrastructure in Europe. Its core product is an AI-powered trading platform called Kronos X.

🚀 The Big Move: BayesShield Enters Healthcare

Perpetuals is taking its proprietary AI technology, BayesShield, and applying it to a new field: healthcare diagnostics.

• The Original Use: BayesShield was built to predict trading outcomes and identify skilled traders by cutting through market "noise" and behavioral biases.
• The New Application: BayesShield Clinical uses the same statistical methodology to analyze physician performance. It doesn't diagnose patients. Instead, it identifies which doctors are most accurate at diagnosing specific types of cases.
• The Goal: Route patients to the right specialist from the start, improving outcomes and reducing costly errors.

👉 Why it matters: The company is leveraging its core AI competency (analyzing decision-making under uncertainty) to attack a massive, expensive problem in a totally different sector.

⚠️ The Problem They're Solving: Diagnostic Errors

The filing paints a stark picture of the healthcare issue Perpetuals aims to address:

• Human Cost: An estimated 795,000 patients in the U.S. die or are permanently disabled each year due to diagnostic errors.
• Systemic Bias: Studies show cognitive biases contribute to diagnostic inaccuracy in up to 77% of scenarios.
• Defensive Medicine: 80-90% of physicians admit to practicing "defensive medicine" (ordering unnecessary tests) to avoid malpractice risk, which hides their true diagnostic skill.
• Financial Cost: This leads to an estimated $210 billion spent annually on unnecessary medical services in the U.S. alone.

🔍 How BayesShield Clinical Works

The technology is designed to be a tool for hospitals and health systems, not a replacement for doctors.

1. It analyzes vast amounts of diagnostic data.
2. It strips away behavioral biases and noise.
3. It identifies statistically significant patterns of diagnostic strength for specific case types.
4. Hospitals can use these insights for optimized case routing, creating better second-opinion protocols, and designing targeted training programs.

👉 Why it matters: It shifts the focus from a subjective "best doctor" to an objective, data-driven analysis of "the best doctor for this specific condition."

🤝 The Partnership with EIM

Perpetuals isn't going it alone. They've partnered with the European Institute of Management (EIM) to handle the clinical rollout.

• Perpetuals' Role: Provides the BayesShield Clinical software platform.
• EIM's Role: Works directly with partner hospitals to manage pilot deployments, design trials, and provide academic oversight through its PhD in Healthcare Studies program.
• Status: Additional hospital and research partnerships are in development.

💡 The Core Analogy & Connection

The entire strategy hinges on one key insight: Financial markets and clinical diagnosis are both about making high-stakes decisions with incomplete information, where skill is often hidden by bias and randomness.

Perpetuals' bet is that an AI built to find the "signal" of true skill in the noisy world of trading can find the same signal in the noisy world of medicine.

🧠 The Analogy

Imagine a hospital is like a busy, chaotic trading floor. Doctors are making rapid "trades" (diagnoses) under pressure. BayesShield is like a super-smart analytics system that watches every move and says, "Based on thousands of past cases, Dr. Smith has an uncanny accuracy in diagnosing rare heart conditions, while Dr. Jones is the go-to expert for complex neurological cases." It helps match the right "trader" to the right "market."

🧩 Final Takeaway

Perpetuals is a trading AI company making a bold pivot into healthcare. Their plan is to repurpose their core technology to solve the billion-dollar problem of diagnostic errors, starting with a pilot partnership with a European academic institute. This represents a significant diversification of their business model.